{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:46:53Z","timestamp":1792716413646,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.placenta.2010.06.005","type":"journal-article","created":{"date-parts":[[2010,7,9]],"date-time":"2010-07-09T04:18:55Z","timestamp":1278649135000},"page":"653-664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Hyperglycosylated hCG, a review"],"prefix":"10.1016","volume":"31","author":[{"given":"L.A.","family":"Cole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2010.06.005_bib1","unstructured":"Rao CV. Paradigm shift on the targets of hCG actions. In: Cole LA, editor. Human chorionic gonadotropin. Oxford: Elsevier, in press."},{"key":"10.1016\/j.placenta.2010.06.005_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-2001-13906","article-title":"An overview of the past, present and future of nongonadal LH\/hCG actions in reproductive biology and medicine","volume":"19","author":"Rao","year":"2001","journal-title":"Sem Reprod Endocrinol"},{"key":"10.1016\/j.placenta.2010.06.005_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1210\/jcem-70-2-421","article-title":"The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua","volume":"70","author":"Reshef","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.placenta.2010.06.005_bib4","first-page":"144","article-title":"Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG-regulated neoplasia","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.placenta.2010.06.005_bib5","first-page":"919","article-title":"Hyperglycosylated hCG in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis","volume":"51","author":"Cole","year":"2006","journal-title":"J Reprod Med"},{"key":"10.1016\/j.placenta.2010.06.005_bib6","unstructured":"Butler SA, Iles RK. Biological function of the free beta subunit: expression and treatment target in cancer. In: Cole LA, editor. Human chorionic gonadotropin. Oxford UK: Elsevier, in press."},{"key":"10.1016\/j.placenta.2010.06.005_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/bjc.1996.56","article-title":"The effects of \u03b2-human chorionic gonadotropin on the in vitro growth of bladder cancer cell lines","volume":"73","author":"Gillott","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.placenta.2010.06.005_bib8","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1002\/(SICI)1097-0142(19961201)78:11<2388::AID-CNCR18>3.0.CO;2-X","article-title":"Metastatic phenotype correlates with high expression of membrane-associated complete \u03b2-human chorionic gonadotropin in vivo","volume":"78","author":"Acevedo","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.placenta.2010.06.005_bib9","doi-asserted-by":"crossref","first-page":"14126","DOI":"10.1016\/S0021-9258(17)43832-4","article-title":"Structures of the asparagine-linked sugar chains of human chorionic gonadotropin produced in choriocarcinoma. Appearance of triantennary sugar chains and unique biantennary sugar chains","volume":"258","author":"Mizuochi","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.placenta.2010.06.005_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0006-291X(85)90610-2","article-title":"The structures of the serine-linked sugar chains on human chorionic gonadotropin","volume":"126","author":"Cole","year":"1985","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1016\/j.placenta.2010.06.005_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1210\/jcem-65-4-811","article-title":"The O-linked oligosaccharides are strikingly different on pregnancy and choriocarcinoma hCG","volume":"65","author":"Cole","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.placenta.2010.06.005_bib12","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/glycob\/cwl034","article-title":"Site-specific glycan analysis of human chorionic gonadotropin \u03b2-subunit from malignancies and pregnancy by liquid chromatography - electrospray mass spectrometry","volume":"16","author":"Valmu","year":"2006","journal-title":"Glycobiol"},{"key":"10.1016\/j.placenta.2010.06.005_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02778058","article-title":"Carbohydrate and peptide structure of the alpha- and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma","volume":"7","author":"Elliott","year":"1997","journal-title":"Endocrine"},{"key":"10.1016\/j.placenta.2010.06.005_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0925-4439(99)00060-5","article-title":"Structure, pathology and function of the N-linked sugar chains of human chorionic gonadotropin","volume":"1455","author":"Kobata","year":"1990","journal-title":"Biochim Biophy Acta"},{"key":"10.1016\/j.placenta.2010.06.005_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/ENDO:10:2:137","article-title":"Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG","volume":"10","author":"Birken","year":"1999","journal-title":"Endocrine"},{"key":"10.1016\/j.placenta.2010.06.005_bib16","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/clinchem\/45.12.2109","article-title":"Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening","volume":"45","author":"Cole","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.placenta.2010.06.005_bib17","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/(SICI)1097-0223(199812)18:12<1232::AID-PD439>3.0.CO;2-Z","article-title":"Differential urinary gonadotropin profiles in early pregnancy and early pregnancy loss","volume":"18","author":"O\u2019Connor","year":"1999","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2010.06.005_bib18","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.fertnstert.2007.03.010","article-title":"Hyperglycosylated human chorionic gonadotropin and the source of pregnancy failure","volume":"89","author":"Sasaki","year":"2008","journal-title":"Fert Steril"},{"key":"10.1016\/j.placenta.2010.06.005_bib19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0009-9120(03)00108-5","article-title":"Hyperglycosylated hCG (Invasive trophoblast antigen, ITA) a Key antigen for early pregnancy detection","volume":"36","author":"Cole","year":"2003","journal-title":"Clin Biochem"},{"key":"10.1016\/j.placenta.2010.06.005_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2009.09.028","article-title":"hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases","volume":"116","author":"Cole","year":"2010","journal-title":"Gyn Oncol"},{"key":"10.1016\/j.placenta.2010.06.005_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0303-7207(02)00135-1","article-title":"Trophoblast origin of hCG isoforms: Cytotrophoblasts are the primary source of choriocarcinoma hCG","volume":"194","author":"Kovalevskaya","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.placenta.2010.06.005_bib22","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1210\/en.2007-0286","article-title":"Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-a","volume":"148","author":"Handshuh","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.placenta.2010.06.005_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jri.2009.04.007","article-title":"hCG and hyperglycosylated hCG in the establishment and evolution of hemochorial placentation","volume":"82","author":"Cole","year":"2009","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.placenta.2010.06.005_bib24","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1210\/jc.2004-2458","article-title":"Transfection of antisense chorionic gonadotropin \u03b2 gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis","volume":"90","author":"Hamade","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.placenta.2010.06.005_bib25","first-page":"147","article-title":"Human chorionic gonadotropin promotes tumorigenesis of choriocarcinoma JAR cells","volume":"13","author":"Lei","year":"1999","journal-title":"Troph Res"},{"key":"10.1016\/j.placenta.2010.06.005_bib26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/369455a0","article-title":"Crystal structure of human chorionic gonadotropin","volume":"369","author":"Lapthorn","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.placenta.2010.06.005_bib27","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1210\/endo-129-3-1559","article-title":"The heterogeneity of hCG: III. The occurrence, biological and immunological activities of nicked hCG","volume":"129","author":"Cole","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.placenta.2010.06.005_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<429::AID-IJC20>3.0.CO;2-1","article-title":"SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype I Mechanisms responsible for hyperinvasiveness and resistance to anti-invasive action of TGF\u03b2","volume":"77","author":"Khoo","year":"1998","journal-title":"Intl J Cancer"},{"key":"10.1016\/j.placenta.2010.06.005_bib29","first-page":"1553","article-title":"The increase in bladder carcinoma cell population induced by the free beta subunit of hCG is a result of an anti-apoptosis effect and not cell proliferation","volume":"82","author":"Butler","year":"2000","journal-title":"Brit J Cancer"},{"key":"10.1016\/j.placenta.2010.06.005_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-001-0479-6","article-title":"Mechanisms of TGF-\u03b2-mediated apoptosis","volume":"307","author":"Schuster","year":"2002","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.placenta.2010.06.005_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0168-8278(99)80007-5","article-title":"Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver regulation by TNF-alpha and TGF-beta1","volume":"30","author":"Knittel","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.placenta.2010.06.005_bib32","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1056\/NEJMra000763","article-title":"Implantation and the survival of early pregnancy","volume":"345","author":"Norwitz","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.placenta.2010.06.005_bib33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/humupd\/dml016","article-title":"Placenta-related disease of pregnancy: involvement of oxidative stress and implications in human evolution","volume":"12","author":"Jauniaux","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.placenta.2010.06.005_bib34","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/clinchem\/45.12.2109","article-title":"Hyperglycosylated hCG (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening","volume":"45","author":"Cole","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.placenta.2010.06.005_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2006.05.010","article-title":"Determination of hyperglycosylated human chorionic gonadotropin produced by malignant gestational trophoblastic neoplasias and male germ cell tumors using a lectin-based immunoassay and surface plasmon resonance","volume":"260","author":"Kelly","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.placenta.2010.06.005_bib36","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/pd.351","article-title":"Maternal serum hyperglycosylated human chorionic gonadotrophin (HhCG) in the first trimester of pregnancies affected by Down syndrome, using a sialic acid-specific lectin immunoassay","volume":"22","author":"Spencer","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2010.06.005_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pd.507","article-title":"Detection of maternal serum glycoform variants in the secont trimester of pregnancies affected by Down syndrome using a lectin immunoassay","volume":"23","author":"Talbot","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2010.06.005_bib38","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1373\/clinchem.2003.026989","article-title":"Higgins, Cembrowski GS. Between-method variation in hCG test results","volume":"50","author":"Cole","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.placenta.2010.06.005_bib39","unstructured":"Cole LA. Over-the-counter pregancy tests. In: Cole LA, editor. Human chorionic gonadotropin. Oxford UK: Elsevier, in press."},{"key":"10.1016\/j.placenta.2010.06.005_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/14737159.9.1.51","article-title":"Human chorionic gonadotropin and associated molecules","volume":"9","author":"Cole","year":"2009","journal-title":"Expert Rev Molec Diag"},{"key":"10.1016\/j.placenta.2010.06.005_bib41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ygyno.2008.09.030","article-title":"The quagmire of hCG and hCG testing in gynecologic oncology","volume":"112","author":"Muller","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.placenta.2010.06.005_bib42","series-title":"Gestational trophoblastic disease","first-page":"130","article-title":"Use of hCG tests for evaluating trophoblastic diseases: choosing an appropriate hCG assay, false detection of hCG, unexplained elevated hCG, and quiescent trophoblastic disease","author":"Cole","year":"2002"},{"key":"10.1016\/j.placenta.2010.06.005_bib43","first-page":"150","article-title":"Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.placenta.2010.06.005_bib44","first-page":"499","article-title":"Hyperglycosylated hCG and its free \u03b2-subunit, tumor markers and tumor promoters: a review","volume":"53","author":"Cole","year":"2008","journal-title":"J Reprod Med"},{"key":"10.1016\/j.placenta.2010.06.005_bib45","first-page":"5","article-title":"Clinical management of persistent low-level hCG elevation","volume":"4","author":"Hancock","year":"2003","journal-title":"Trophobl Dis Upd"},{"key":"10.1016\/j.placenta.2010.06.005_bib46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/gyno.2002.6622","article-title":"Persistent low-level \u201creal\u201d human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma","volume":"85","author":"Kohorn","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.placenta.2010.06.005_bib47","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2004.02.018","article-title":"Survival rates of patients with choriocarcinoma treated with chemotherapy without hysterectomy: effects of anticancer agents on subsequent births","volume":"93","author":"Goto","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.placenta.2010.06.005_bib48","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/ijgc-00009577-200605000-00074","article-title":"Results with EMA\/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia","volume":"16","author":"Turan","year":"2006","journal-title":"Intl J Gynecol Oncol"},{"key":"10.1016\/j.placenta.2010.06.005_bib49","first-page":"3700","article-title":"Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down\u2019s syndrome","volume":"85","author":"Frendo","year":"2000","journal-title":"J Clin Edocrinol Metab"},{"key":"10.1016\/j.placenta.2010.06.005_bib50","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/pd.1970070904","article-title":"Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities","volume":"7","author":"Bogart","year":"1987","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2010.06.005_bib51","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1471-0528.1988.tb06602.x","article-title":"Maternal serum unconjugated oestriol as an antenatal screening test for Down\u2019s syndrome","volume":"95","author":"Wald","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.placenta.2010.06.005_bib52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F","article-title":"Prenatal screening for Down syndrome using inhibin A as a serum marker","volume":"16","author":"Wald","year":"1996","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2010.06.005_bib53","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/bmj.304.6831.867","article-title":"Fetal nuchal translucency: ultrasound screening for chromosomal defects in the first trimester of pregnancy","volume":"304","author":"Nicolaides","year":"1992","journal-title":"Br Med J"},{"key":"10.1016\/j.placenta.2010.06.005_bib54","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1373\/clinchem.2003.023986","article-title":"Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) in second-trimester maternal urine as a marker for Down syndrome: preliminary results of an observational study on fresh samples","volume":"50","author":"Palomaki","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.placenta.2010.06.005_bib55","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1373\/clinchem.2005.050567","article-title":"Maternal serum invasive trophoblast antigen and first-trimester Down syndrome screening","volume":"51","author":"Palomaki","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.placenta.2010.06.005_bib56","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/pd.329","article-title":"The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent preeclampsia","volume":"22","author":"Bahado-Singh","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2010.06.005_bib57","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/humrep\/14.6.1642","article-title":"Human chorionic gonadotropin concentrations in early pregnancy after in-vitro fertilization","volume":"14","author":"Bjercke","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.placenta.2010.06.005_bib58","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/(SICI)1097-0223(199812)18:12<1232::AID-PD439>3.0.CO;2-Z","article-title":"Differential urinary gonadotropin profiles in early pregnancy and early pregnancy loss","volume":"18","author":"O\u2019Connor","year":"1999","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.placenta.2010.06.005_bib59","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1677\/joe.0.1720497","article-title":"Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope","volume":"172","author":"Kovalevskaya","year":"2002","journal-title":"J Endocrinol"},{"key":"10.1016\/j.placenta.2010.06.005_bib60","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.clinbiochem.2006.03.020","article-title":"A single serum test for measuring early pregnancy outcome with high predictive value","volume":"39","author":"Sutton-Riley","year":"2006","journal-title":"Clin Biochem"},{"key":"10.1016\/j.placenta.2010.06.005_bib61","first-page":"449","article-title":"Evolution of the human brain, chorionic gonadotropin and hemochorial implantation of the placenta: insights into origins of pregnancy failures, preeclampsia and choriocarcinoma","volume":"53","author":"Cole","year":"2008","journal-title":"J Reprod Med"},{"key":"10.1016\/j.placenta.2010.06.005_bib62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jri.2009.04.007","article-title":"hCG and hyperglycosylated hCG in the establishment and evolution of hemochorial placentation","volume":"82","author":"Cole","year":"2009","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.placenta.2010.06.005_bib63","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/281351a0","article-title":"The cDNA of the \u00df-subunit of human chorionic gonadotropin suggests evolution of a gene by readthrough into the 3\u2032 untranslated region","volume":"281","author":"Fiddes","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.placenta.2010.06.005_bib64","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/oxfordjournals.molbev.a004085","article-title":"Chorionic gonadotropin has a recent origin within primates and an evolutionary history of selection","volume":"19","author":"Maston","year":"2002","journal-title":"Molec Biol Evol"},{"key":"10.1016\/j.placenta.2010.06.005_bib65","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.280.5368.1345","article-title":"Solving the brain\u2019s energy crisis","volume":"280","author":"Gibbons","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.placenta.2010.06.005_bib66","first-page":"149","article-title":"Scaling of the mammalian barrier: the maternal energy hypothesis","volume":"4","author":"Martin","year":"1996","journal-title":"News Physiol Sci"},{"key":"10.1016\/j.placenta.2010.06.005_bib67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/026010609300900307","article-title":"The importance of energy and nutrient supply in human brain evolution","volume":"9","author":"Cunnane","year":"1993","journal-title":"Nutr Health"},{"key":"10.1016\/j.placenta.2010.06.005_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/293057a0","article-title":"Relative brain size and basal metabolic rate in terrestrial vertebrates","volume":"293","author":"Martin","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.placenta.2010.06.005_bib69","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1056\/NEJMra000763","article-title":"Implantation and the survival of early pregnancy","volume":"345","author":"Norwitz","year":"2001","journal-title":"New Engl J Med"},{"key":"10.1016\/j.placenta.2010.06.005_bib70","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/humupd\/dml016","article-title":"Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution","volume":"12","author":"Jauniaux","year":"2006","journal-title":"Hum Reprod Updt"},{"key":"10.1016\/j.placenta.2010.06.005_bib71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-0378(03)00040-8","article-title":"Preeclampsia and human reproduction. An essay of a long term reflection","volume":"59","author":"Robillard","year":"2003","journal-title":"J Reprod Immunol"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400410002225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400410002225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:42:16Z","timestamp":1758908536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400410002225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":71,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0143400410002225"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2010.06.005","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperglycosylated hCG, a review","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2010.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}